CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
truSculptdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03433430
NCT03433430N/ACompleted

This is an Exploratory Multi-center, Pilot Study to Evaluate the Safety, Efficacy and Ergonomics of Cutera truSculpt Device. Subjects May Receive up to Three Treatments and Will be Followed at 12 Weeks Post the First and Final Treatment.

Cutera Inc.·interventional·Posted Feb 14, 2018·Updated Sep 18, 2023

In Brief

A clinical study evaluating truSculpt for Bulging and Body Fat. Completed, enrolled 9 participants across 3 sites.

Detailed Summary

An exploratory pilot study to evaluate the safety, efficacy and ergonomics of Cutera truSculpt device

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBulging, Body Fat
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 14, 2018
Enrollment StartAug 17, 2017
Primary CompletionMar 7, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.4 years ago

Interventions

truSculptdevice

Subjects will receive utreatments and will be followed at 12 weeks post final treatment.